Monday, November 16, 2026

More on Demexit and pushing Joe Biden

Biden cannot just assume that Bernie’s supporters will vote for him out of fear of Trump.

V-E Day plus 75

The “new times” upon which the nation has now embarked will pose their own distinctive challenges, as the Covid-19 pandemic makes unmistakably clear.

3 Reasons a New President Won’t Help America

We need a guaranteed income. It's the one way we could immediately instill a degree of equality in America, while restoring some of the missing trust in each other.

‘Earth will be annihilated:’ On 73rd anniversary of Hiroshima bombing, a warning against nuclear...

In remembrance, we turn to the words of a Hiroshima survivor, or hibakusha.

Former Pennsylvania Treasurer sentenced to prison for attempted extortion

“When an individual’s ambition trumps his or her good judgment and their otherwise good character, that’s when crimes happen… "

Police under investigation after fatally shooting unarmed teen in back

According to Raye’s mother, Karonisha Ramsey, her son had called her a few hours before his death to tell her that he would be home for Thanksgiving dinner.

Progressive Briefing for Thursday, September 6

New study links air pollution to dementia, U.K. accuses Russian spies of implementing nerve agent attack, anonymous White House official publishes scathing NYT op-ed, and more.

Our times call for managing complexities, not solving problems

How Paicines Ranch in California works to bring business and investment up to date with our times and closer to nature—prioritizing ecosystem health, habitat, and the sequestration of carbon through soil practices.

BREAKING: 12 dead after mass shooting took place at a bar in California

The gunman, Ian David Long, who was a Marine Corps veteran, killed at least 12 people at the bar and country music hall in Thousand Oaks.

Drug prices soar under Trump despite promises, Senate report finds

Senate HELP Minority report says 688 drug prices rose after Trump took office, with some cancer therapies now over $200,000 a year and a rare-disease drug jumping 1,555 percent; White House tariffs and the One Big Beautiful Bill Act could push costs higher still.